Nov 14 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* Qtrly total revenue $1.1 million versus $29,000 last year
* Crescita Therapeutics Inc - qtrly net loss from continuing operations (excluding immunology group which was discontinued) was $1.4 million versus $2.3 million
* Crescita Therapeutics(tm) announces 2016 third quarter results Source text for Eikon: ID:nCNWNJg1ma Further company coverage: CTX.TO